{"id":6384,"date":"2018-04-10T13:09:57","date_gmt":"2018-04-10T17:09:57","guid":{"rendered":"http:\/\/blogs.cdc.gov\/safehealthcare\/?page_id=6384"},"modified":"2024-11-08T14:11:22","modified_gmt":"2024-11-08T18:11:22","slug":"michael-craig-mpp","status":"publish","type":"page","link":"https:\/\/blogs.cdc.gov\/safehealthcare\/bios\/michael-craig-mpp\/","title":{"rendered":"Michael Craig, MPP"},"content":{"rendered":"<figure id=\"attachment_6385\" aria-describedby=\"caption-attachment-6385\" style=\"width: 275px\" class=\"wp-caption alignright\"><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-6385\" src=\"https:\/\/blogs.cdc.gov\/wp-content\/uploads\/sites\/11\/2018\/03\/Michael-Craig-portrait.jpg\" alt=\"Michael Craig, MPP\" width=\"275\" height=\"393\" srcset=\"https:\/\/blogs.cdc.gov\/safehealthcare\/wp-content\/uploads\/sites\/11\/2018\/03\/Michael-Craig-portrait.jpg 600w, https:\/\/blogs.cdc.gov\/safehealthcare\/wp-content\/uploads\/sites\/11\/2018\/03\/Michael-Craig-portrait-210x300.jpg 210w\" sizes=\"(max-width: 275px) 100vw, 275px\" \/><figcaption id=\"caption-attachment-6385\" class=\"wp-caption-text\">Michael Craig, MPP<br \/>Senior Advisor for Antibiotic Resistance<br \/>Antibiotic Resistance Coordination and Strategy Unit<\/figcaption><\/figure>\n<h1>Michael Craig, MPP<\/h1>\n<p>Michael Craig serves as Director of the Antimicrobial Resistance Coordination and Strategy Unit (ARX) at CDC, which leads U.S. public health efforts to combat antimicrobial resistance (AR). Since 2016, Craig has overseen the agency\u2019s domestic and global portfolio, which now totals nearly $200 million annually. As of fiscal year 2024, Craig has overseen over $1.6 billion in cumulative appropriations for cross-cutting CDC activities to combat AR threats across human and animal health and the environment.<\/p>\n<p>Craig has led efforts to publish multiple high-profile CDC reports, including the <a href=\"https:\/\/www.cdc.gov\/antimicrobial-resistance\/data-research\/threats\/index.html\">Antibiotic Resistance Threats Report<\/a>s (2013, 2019), the <a href=\"https:\/\/www.cdc.gov\/antimicrobial-resistance\/data-research\/threats\/covid-19.html\">COVID-19: U.S. Impact on Antimicrobial Resistance, Special Report<\/a> (2022) and <a href=\"https:\/\/www.cdc.gov\/antimicrobial-resistance\/data-research\/threats\/update-2022.html\">Antimicrobial Resistance Threats in the United States, 2021-2022<\/a> (2024). Craig also led CDC contributions to the first <a href=\"https:\/\/www.cdc.gov\/antimicrobial-resistance\/programs\/AR-actions-events.html\">National Strategy to Combat Antibiotic Resistant Bacteria<\/a> and the subsequent National Action Plans in 2015 and 2020. From 2018-2019, Craig\u2019s team led the AMR Challenge, a yearlong effort by the U.S. government to accelerate the fight against antimicrobial resistance, resulting in more than 350 organizations across 32 countries committing to actions to slow antimicrobial resistance.<\/p>\n<p>Craig also serves as the Deputy Division Director for Strategy and Operations in CDC\u2019s Division of Healthcare Quality Promotion. In this position, he guides strategy to protect patients and healthcare workers through safe healthcare delivery systems in the United States and abroad. During his time in DHQP, Craig has played an integral role in expanding the national visibility of public health initiatives dedicated to safe healthcare delivery, improving sepsis early detection and treatment, infection prevention and control, blood, organ, and tissue safety, and vaccine safety.<\/p>\n<p>As one of the Ex-Officio Members representing CDC on the President\u2019s Advisory Committee for Combatting Antibiotic-Resistant Bacteria (PACCARB), Craig collaborates closely with leadership within HHS to ensure alignment of public health activities related to AR across multiple federal agencies.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Michael Craig, MPP Michael Craig serves as Director of the Antimicrobial Resistance Coordination and Strategy Unit (ARX) at CDC, which leads U.S. public health efforts to combat antimicrobial resistance (AR). Since 2016, Craig has overseen the agency\u2019s domestic and global portfolio, which now totals nearly $200 million annually. As of fiscal year 2024, Craig has<\/p>\n","protected":false},"author":192,"featured_media":0,"parent":140,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"_links":{"self":[{"href":"https:\/\/blogs.cdc.gov\/safehealthcare\/wp-json\/wp\/v2\/pages\/6384"}],"collection":[{"href":"https:\/\/blogs.cdc.gov\/safehealthcare\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/blogs.cdc.gov\/safehealthcare\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.cdc.gov\/safehealthcare\/wp-json\/wp\/v2\/users\/192"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.cdc.gov\/safehealthcare\/wp-json\/wp\/v2\/comments?post=6384"}],"version-history":[{"count":10,"href":"https:\/\/blogs.cdc.gov\/safehealthcare\/wp-json\/wp\/v2\/pages\/6384\/revisions"}],"predecessor-version":[{"id":8385,"href":"https:\/\/blogs.cdc.gov\/safehealthcare\/wp-json\/wp\/v2\/pages\/6384\/revisions\/8385"}],"up":[{"embeddable":true,"href":"https:\/\/blogs.cdc.gov\/safehealthcare\/wp-json\/wp\/v2\/pages\/140"}],"wp:attachment":[{"href":"https:\/\/blogs.cdc.gov\/safehealthcare\/wp-json\/wp\/v2\/media?parent=6384"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}